Phase I study of Debio1143 (AT406) in combination with daunorubicin (D) and cytarabine (C) in patients with poor-risk acute myeloid leukemia (AML).


Conference Paper

Full Text

Duke Authors

Cited Authors

  • DiPersio, JF; Erba, HP; Larson, RA; Luger, SM; Mangan, KF; Tallman, MS; Brill, JM; Vuagniaux, G; Rouits, E; Zanna, C; Sorensen, JM

Published Date

  • May 20, 2014

Published In

Volume / Issue

  • 32 / 15_suppl

Start / End Page

  • 7029 - 7029

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2014.32.15_suppl.7029